default author photo

Prabin Dahal

University of Oxford - Infectious Diseases Data Observatory - IDDO

SCHOLARLY PAPERS

5

DOWNLOADS

355

TOTAL CITATIONS

1

Scholarly Papers (5)

1.

A Systematic Review of the Clinical Study Landscape for Eumycetoma, 1990-2024

Number of pages: 35 Posted: 29 Jul 2025
Medical University of Vienna - Department of Epidemiology, University of Oxford - Infectious Diseases Data Observatory - IDDO, Hospital General de México "Doctor Eduardo Liceaga", University of Oxford, Medical University of Vienna, University of Oxford, Medical University of Vienna, University of Oxford, Drugs for Neglected Diseases Initiative (DNDi), Medical University of Vienna, University of Vienna - University of Applied Sciences Technikum Wien, Drugs for Neglected Diseases Initiative (DNDi), Hospital General de México "Doctor Eduardo Liceaga", Medical University of Vienna, University of Khartoum - Mycetoma Research Centre, Drugs for Neglected Diseases Initiative (DNDi) and University of Oxford - Infectious Diseases Data Observatory - IDDO
Downloads 115 (659,652)

Abstract:

Loading...

mycetoma, neglected tropical diseases, fungal infections

2.

Optimal Long-Acting Antimalarial Regimens for Seasonal Malaria Chemoprevention: Mapping Review and Network Meta-Analysis

Number of pages: 36 Posted: 01 Jul 2026
University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, Université Paris Cité, IRD, Inserm, MERIT, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO and University of Oxford - Infectious Diseases Data Observatory - IDDO
Downloads 75

Abstract:

Loading...

Seasonal malaria chemoprevention, Network meta-analysis

3.

Epidemiological Shifts and Trends in Visceral Leishmaniasis Incidence, Relapse, and Mortality in Brazil, 2007-2023: Analysis Using National Notifiable Diseases Information System (SINAN)

Number of pages: 34 Posted: 31 Oct 2025
Dilla University College of Health Science and MedicineAddis Ababa University - Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), - Instituto René Rachou (IRR), University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Centre for Tropical Medicine and Global Health, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO and University of Oxford - Infectious Diseases Data Observatory - IDDO
Downloads 72 (867,774)

Abstract:

Loading...

Visceral Leishmaniasis, Epidemiology, Brasil, South America

4.

Estimating the Proportion of Relapse Following Treatment of Visceral Leishmaniasis: Meta-Analysis Using Infectious Diseases Data Observatory (IDDO) Living Systematic Review

Number of pages: 42 Posted: 02 Jun 2023
University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, Banaras Hindu University (BHU) - Infectious Disease Research Laboratory, Drugs for Neglected Diseases Initiative (DNDi), University of Oxford - Infectious Diseases Data Observatory - IDDO and University of Oxford - Infectious Diseases Data Observatory - IDDO
Downloads 69 (899,324)
Citation 1

Abstract:

Loading...

Visceral Leishmaniasis, kala-azar, systematic review, relapse, efficacy, meta-analysis, resistance, Liposomal Amphotericin B (L-AmB), Amphotericin B, Pentavalent antimonial, Miltefosine, Sitamaquine, Pentamidine, Paromomycin

5.

Time From Symptom Onset to Treatment Initiation in Visceral Leishmaniasis In Brazil, 2007–2023: A National Notifiable Disease Registry-Based Study

Number of pages: 25 Posted: 26 Jun 2026
Universidad de la Sabana, University of Oxford - Infectious Diseases Data Observatory - IDDO, Dilla University College of Health Science and MedicineAddis Ababa University - Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), University of Oxford - Infectious Diseases Data Observatory - IDDO, University of Oxford - Infectious Diseases Data Observatory - IDDO, Universidad ICESI, - Instituto René Rachou (IRR) and University of Oxford - Infectious Diseases Data Observatory - IDDO
Downloads 24

Abstract:

Loading...

Visceral leishmaniasis, Kala-azar, Time-to-treatment, Treatment delay, Mortality, Brazil